1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > CNS Drug News 02 NOVEMBER 2015

CNS Drug News 02 NOVEMBER 2015

  • November 2015
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Teva's Revenues Fall But Copaxone And Specialty Revenues Provide Encouragement
Industry Trend Analysis - Priority Review Heralds New Treatment For Parkinson's Disease Psychosis
Industry Trend Analysis - Biogen To Refocus After Poor Tysabri Results In SPMS
Industry Trend Analysis - Positive Alkermes Trial Results Could Open Up MS Market
Industry Brief - Canbex Initiates Phase II trial Of VSN16R In Spasticity
Industry Trend Analysis - Ketamine-Based Drugs Poised To Be The Future Of Anti-depressant Treatment
Industry Brief - Alexza Plans To Reacquire Rights From Teva For Adasuve In The US
Industry Brief - FDA Approves Dyanavel XR For ADHD
Industry Brief - Impax Gains FDA Guanfacine Approval
Industry Brief - BI/BioMed X Extend Collaboration For Novel Therapeutic In Psychiatric Diseases
Industry Brief - Elite's Abuse-Deterrent ELI-200 Phase III Study Meets Primary Endpoints
Industry Brief - FDA Approves Endo/BDSI's Belbuca For Chronic Pain Management
Industry Brief - Aurobindo Gains FDA Tramadol Approval
Industry Brief - Jubilant Gains FDA Rizatriptan Approval
Industry Brief - Charleston/Daiichi Phase III Study Of CL-108 Met Primary Endpoints
Industry Brief - Orexo Settles Fentanyl Litigation With Actavis
Industry Brief - Insys Announces Naloxone Sublingual Spray Fast Track Designation From FDA
Industry Brief - FDA Accepts Supernus' sNDA For Trokendi Label Expansion
Industry Brief - Neurocrine Initiates Phase II Study Of NBI-98854 In Tourette's
Industry Brief - Pivotal Study Design Of Newron's Sarizotan In Rett Syndrome Planned
Industry Trend Analysis - Biogen's Restructuring Will Lead To A Broader Product Base

Table Of Contents

CNS Drug News 02 NOVEMBER 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


Download Unlimited Documents from Trusted Public Sources

Therapy and Hormone Market in South Korea

  • December 2016
    4 pages
  • Therapy  

    Hormone  

    Cancer  

  • South Korea  

View report >

Opioid Market in the US

  • December 2016
    14 pages
  • Opioid  

  • United States  

View report >

Therapy Market in Denmark - Forecast

  • December 2016
    12 pages
  • Therapy  

  • Denmark  

View report >

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.